XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - USD ($)
 12 Months Ended
Apr. 30, 2020
Jun. 24, 2020
Oct. 31, 2019
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Apr. 30, 2020    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Trading Symbol KALV    
Entity Registrant Name KALVISTA PHARMACEUTICALS, INC.    
Entity Central Index Key 0001348911    
Current Fiscal Year End Date --04-30    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company false    
Document Annual Report true    
Document Transition Report false    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Security Exchange Name NASDAQ    
Entity File Number 001-36830    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 20-0915291    
Entity Address, Address Line One 55 Cambridge Parkway    
Entity Address, Address Line Two Suite 901 East    
Entity Address, City or Town Cambridge    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 02142    
City Area Code 857    
Local Phone Number 999-0075    
Entity Common Stock, Shares Outstanding   17,847,224  
Entity Public Float     $ 164,278,175
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Information required in responses to Part III of Form 10-K is hereby incorporated by reference to portions of the Registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held in 2020. The Proxy Statement will be filed by the Registrant with the Securities and Exchange Commission no later than 120 days after the end of the Registrant’s fiscal year ended April 30, 2020.